CMB International Capital Corporation
VC Fund
Central, Hong Kong
CMB International Capital Corporation is an investment banking firm that offers comprehensive professional services and financial advisory services. It provides mergers and acquisitions, initial public offering, equity underwriting, company restructuring, project financing, and business consulting services. CMB International Capital Corporation provides corporate finance, asset management, wealth management and securities brokerage services. Additionally, it offers debt financing and transaction advisory services, placement of shares and refinancing for listed companies. CMB International Capital Corporation’s clientele include institutional, corporate and individual customers both domestic and overseas. It began operation in 1987, with its headquarters in Central in Hong Kong as a subsidiary of China Merchants Bank.
- Total investments:
- 150
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries CMB International Capital Corporation invests in
Stages CMB International Capital Corporation invests in
Countries CMB International Capital Corporation invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $13M–$142M
- Series B
- $15M–$224M
- Series C
- $35M–$250M
Investment Focus
Industry
- Manufacturing 31 (21%)
- Biotechnology 25 (17%)
- Health Care 24 (16%)
- Medical 14 (9%)
- Artificial Intelligence 13 (9%)
Stage
- Series A 40 (27%)
- Series B 38 (25%)
- Series C 25 (17%)
- Series D 11 (7%)
- Seed 9 (6%)
Country
- China 121 (81%)
- United States 5 (3%)
- Japan 1 (1%)
- Hong Kong 1 (1%)
- Singapore 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Hongbo Wang
Chief Investment Officer
|
Chief Investment Officer | Total investments: 0 | Find email | |
Kexiang Zhou
Managing Director
|
Managing Director | Total investments: 2 | Find email | |
|
Xinghai Zeng
Managing Director
|
Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Zhongke lon engages in the R&D and manufacturing of high-end medical devices such as proton therapy equipment. It is committed to providing full-cycle solutions for the construction and operation of proton therapy centers and creating nuclear technology applications and medical equipment. The company was established in 2016 and is headquartered in Hefei, Anhui, China. | $89.5M / Seed / Sep 29, 2026 | ||
| Founded in 2019, Raysolve is dedicated to the R&D of Micro-LED micro-display technology, in particular chip architecture, fabrication processes and the development of single-chip, full-color technology. The core team stemmed from the Hong Kong University of Science and Technology (HKUST) with decades of experience in the design andmanufacturing of cutting-edge microchips. The team announced the world’s first single-chip full-color Micro-LED micro-display in Silicon Valley in 2019. | $14.9M / Seed / Sep 09, 2026 | ||
| Megawave Fusion focuses on high-power radio frequency transmitters, high-voltage power supplies. | $14.9M / Series A / Sep 07, 2026 | ||
| Shanghai Electric (Group) Corporation designs, develops, and manufactures thermal, nuclear, and wind power equipment in China. The company offers gas turbines, transmission and distribution equipment, elevators, machine tools, refrigeration compressors, environmental protection equipment, automation products, rail transportation equipment, machineparts, generators, and other products. | $222.4M / Post-IPO Debt / Aug 12, 2026 | ||
|
Huilun Technology
|
Huilun Technology is a GAC Group-backed firm focused on full-stack embodied intelligence, developing humanoid robots and components like axial flux motors and dexterous hands. | $14.8M / Seed / Aug 11, 2026 | |
| Huaqiu is an electronic service platform. | Series D / Aug 05, 2026 | ||
| Shandong New Line Bio Inc. researches, manufactures, and sells antibiotic-substitute feed additives. The company develops bacteriophage biological solutions to address drug-resistant bacteria and control bacterial infections in agriculture and animal husbandry. | $14.8M / Series A / Jul 27, 2026 | ||
| Mojie is a technology company that engages in the research and development of optics and AI solutions, known for its extensive development of various core technologies. The company operates research and development offices and high-end manufacturing bases. | $88.5M / Series A / Jul 13, 2026 | ||
| Deepin Intelligent Control is a smart energy innovation company. | $14.7M / Series B / Jul 09, 2026 | ||
| LINCHR specializes in the research and development of energy vehicle charging equipment, on-board charging, new energy microgrid, and intelligent detection, providing one-stop solutions for new energy vehicle applications. | Series C / Jul 07, 2026 | ||
| See all 150 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does CMB International Capital Corporation invest in?
CMB International Capital Corporation invests primarily in Manufacturing, Biotechnology and Health Care startups, most often at Series A and Series B stage. Most of the 150 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does CMB International Capital Corporation invest in?
CMB International Capital Corporation typically joins rounds of $13M–$142M at Series A, $15M–$224M at Series B and $35M–$250M at Series C. These are whole funding-round sizes, not CMB International Capital Corporation's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds CMB International Capital Corporation took part in.
How do I contact CMB International Capital Corporation?
Public channels for CMB International Capital Corporation include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CMB International Capital Corporation?
The team at CMB International Capital Corporation includes Hongbo Wang (Chief Investment Officer), Kexiang Zhou (Managing Director) and Xinghai Zeng (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
